blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3087070

EP3087070 - PYRAZOLO[1,5-A]PYRIDINE DERIVATIVES AND METHODS OF THEIR USE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.09.2018
Database last updated on 28.05.2024
FormerThe patent has been granted
Status updated on  06.10.2017
FormerGrant of patent is intended
Status updated on  16.05.2017
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
Ignyta, Inc.
4545 Towne Centre Ct.
San Diego, CA 92121 / US
[2017/44]
Former [2016/44]For all designated states
Ignyta, Inc.
11111 Flintkote Avenue
San Diego, CA 92121 / US
Inventor(s)01 / HUDKINS, Robert L.
430 S. Saddlebrook Circle
Chester Springs, Pennsylvania 19425 / US
02 / ZULLI, Allison L.
1020 Washington Place
Wayne, Pennsylvania 19807 / US
 [2016/44]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2016/44]
Application number, filing date14824711.718.12.2014
[2016/44]
WO2014US71040
Priority number, dateUS201361920819P26.12.2013         Original published format: US 201361920819 P
[2016/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015100117
Date:02.07.2015
Language:EN
[2015/26]
Type: A1 Application with search report 
No.:EP3087070
Date:02.11.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 02.07.2015 takes the place of the publication of the European patent application.
[2016/44]
Type: B1 Patent specification 
No.:EP3087070
Date:08.11.2017
Language:EN
[2017/45]
Search report(s)International search report - published on:EP02.07.2015
ClassificationIPC:C07D471/04, A61K31/437, A61P35/00
[2016/44]
CPC:
C07D471/04 (EP,KR,US); A61K31/4162 (KR); A61K31/437 (KR);
A61P35/00 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/44]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:PYRAZOLO[1,5-A]PYRIDIN-DERIVATE UND VERFAHREN ZU DEREN VERWENDUNG[2016/44]
English:PYRAZOLO[1,5-A]PYRIDINE DERIVATIVES AND METHODS OF THEIR USE[2016/44]
French:DÉRIVÉS DE PYRAZOLO[1,5-A]PYRIDINE ET LEURS PROCÉDÉS D'UTILISATION[2016/44]
Entry into regional phase22.07.2016National basic fee paid 
22.07.2016Designation fee(s) paid 
22.07.2016Examination fee paid 
Examination procedure22.07.2016Examination requested  [2016/44]
13.03.2017Amendment by applicant (claims and/or description)
17.05.2017Communication of intention to grant the patent
26.09.2017Fee for grant paid
26.09.2017Fee for publishing/printing paid
26.09.2017Receipt of the translation of the claim(s)
Divisional application(s)EP17196014.9  / EP3309160
Opposition(s)09.08.2018No opposition filed within time limit [2018/42]
Fees paidRenewal fee
23.12.2016Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL08.11.2017
CY08.11.2017
EE08.11.2017
HR08.11.2017
LT08.11.2017
LV08.11.2017
MK08.11.2017
RS08.11.2017
SK08.11.2017
SM08.11.2017
MT18.12.2017
BG08.02.2018
IS08.03.2018
[2020/34]
Former [2019/52]CY08.11.2017
EE08.11.2017
HR08.11.2017
LT08.11.2017
LV08.11.2017
MK08.11.2017
RS08.11.2017
SK08.11.2017
SM08.11.2017
MT18.12.2017
BG08.02.2018
IS08.03.2018
Former [2018/43]CY08.11.2017
EE08.11.2017
HR08.11.2017
LT08.11.2017
LV08.11.2017
RS08.11.2017
SK08.11.2017
SM08.11.2017
MT18.12.2017
BG08.02.2018
IS08.03.2018
Former [2018/37]CY08.11.2017
EE08.11.2017
HR08.11.2017
LT08.11.2017
LV08.11.2017
RS08.11.2017
SK08.11.2017
SM08.11.2017
BG08.02.2018
IS08.03.2018
Former [2018/24]HR08.11.2017
LT08.11.2017
LV08.11.2017
RS08.11.2017
BG08.02.2018
IS08.03.2018
Former [2018/22]LT08.11.2017
Cited inInternational search[A]EP2103620  (TAKEDA PHARMACEUTICAL [JP]) [A] 1-95 * claims 1, 12, 13 ** page 125 - page 126; example 137 *;
 [A]CN102827186  (SHANGHAI INST MATERIA MEDICA) [A] 1-95 * claim 1 *;
 [A]WO2013180949  (XI NING [US]) [A] 1-95 * claims 1, 17 * * page 5, paragraph [014] *;
    [ ] - SHEN, JINGKANG ET AL, "Preparation of heterocycles as c-Met inhibitors", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (2012), Database accession no. 2012:1874106, URL: STN, XP002736344 [ ] * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.